Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liquid vs Tissue Biopsy Concordance in Samples of 1st Suspected BCa Recurrence/Metastasis and Evaluation of DefineMBC Comprehensive Cancer Profiling Liquid Biopsy LDT

NCT04962529 is registered in ClinicalTrials.gov with Anthony Magliocco as lead sponsor.

NCT NCT04962529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04962529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liquid vs Tissue Biopsy Concordance in Samples of 1st Suspected BCa Recurrence/Metastasis and Evaluation of DefineMBC Comprehensive Cancer Profiling Liquid Biopsy LDT
Lead sponsor
Anthony Magliocco
Phase
Observational
Overall status
Unknown status
Start date
September 28, 2020
Completion date
July 31, 2023
Enrollment
450 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cancer